When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
Statins are notorious for causing myalgia and sometimes mild elevation of CPK (creatine phosphokinase). Herein, we present a case of necrotizing autoimmune myopathy induced by statins. The patient was on therapy with atorvastatin for about six years before she started developing myalgia and mild ele...
Saved in:
Main Authors: | Elena Obreja, Pamela Sequeira, Diana Girnita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2018/1215653 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges in Treating Statin-Associated Necrotizing Myopathy
by: Patrick Webster, et al.
Published: (2021-01-01) -
Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy
by: Nathan G. DeRon, et al.
Published: (2023-01-01) -
When herpes zoster is not herpes: A case of statin-induced myopathy complicated by drug allergies
by: Hira Khalid Kareem, et al.
Published: (2025-01-01) -
Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy
by: Thomas C. Bolig, et al.
Published: (2020-01-01) -
The Underlying Mechanisms of Diabetic Myopathy
by: Erick O. Hernández-Ochoa, et al.
Published: (2017-01-01)